Biomarkers for response to TIL therapy: a comprehensive review
Adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has demonstrated durable clinical responses in patients with metastatic melanoma, substantiated by recent positive results of the first phase III trial on TIL therapy. Being a demanding and logistically complex treatment, extensive prec...
| الحاوية / القاعدة: | Journal for ImmunoTherapy of Cancer |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
BMJ Publishing Group
2024-03-01
|
| الوصول للمادة أونلاين: | https://jitc.bmj.com/content/12/3/e008640.full |